Nexalin Technology (NXL) Depreciation & Amortization (CF) (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Depreciation & Amortization (CF) of $4106.0 in Q1 2026, up 3965.35% quarter-over-quarter from $101.0 in Q4 2023.
Nexalin Technology (NXL) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Nexalin Technology's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $4106.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed N/A year-over-year to $4106.0; the TTM figure through Mar 2026 stood at $4106.0 (changed N/A YoY), while the FY2023 annual figure was $503.0, down 5.98% from the prior year.
- Depreciation & Amortization (CF) was $4106.0 for Q1 2026 at Nexalin Technology, up from $101.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $4106.0 in Q1 2026 to a low of $101.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $571.56 across 3 years, with a median of $134.0 in 2022.
- Biggest YoY gain for Depreciation & Amortization (CF) was 0.0% in 2023; the steepest drop was 23.48% in 2023.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $132.0 in 2022, then retreated by 23.48% to $101.0 in 2023, then jumped by 3965.35% to $4106.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $4106.0 (Q1 2026), $101.0 (Q4 2023), and $134.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 4,106.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,106.00 |
| Mar 31, 2026 | 4,106.00 |
| Dec 31, 2023 | 101.00 |
| Dec 31, 2023 | 101.00 |
| Sep 30, 2023 | 134.00 |
| Sep 30, 2023 | 134.00 |
| Jun 30, 2023 | 134.00 |
| Jun 30, 2023 | 134.00 |
| Mar 31, 2023 | 134.00 |
| Mar 31, 2023 | 134.00 |
| Dec 31, 2022 | 132.00 |
| Dec 31, 2022 | 132.00 |
| Sep 30, 2022 | 135.00 |
| Sep 30, 2022 | 135.00 |
| Jun 30, 2022 | 134.00 |
| Jun 30, 2022 | 134.00 |
| Mar 31, 2022 | 134.00 |
| Mar 31, 2022 | 134.00 |
| Dec 31, 2021 | 134.00 |
| Dec 31, 2021 | 134.00 |